Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v2.4.1.9
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended
Mar. 31, 2015
Mar. 31, 2014
COSTS AND EXPENSES:    
Research and development $ 6,829us-gaap_ResearchAndDevelopmentExpense $ 3,550us-gaap_ResearchAndDevelopmentExpense
General and administrative 2,867us-gaap_GeneralAndAdministrativeExpense 1,619us-gaap_GeneralAndAdministrativeExpense
Total operating expenses 9,696us-gaap_OperatingExpenses 5,169us-gaap_OperatingExpenses
Operating Loss (9,696)us-gaap_OperatingIncomeLoss (5,169)us-gaap_OperatingIncomeLoss
Interest income, net 15us-gaap_InterestIncomeExpenseNet 5us-gaap_InterestIncomeExpenseNet
NET LOSS $ (9,681)us-gaap_NetIncomeLoss $ (5,164)us-gaap_NetIncomeLoss
Net loss per common share, basic and diluted (in dollars per share) $ (0.71)us-gaap_EarningsPerShareBasicAndDiluted $ (0.59)us-gaap_EarningsPerShareBasicAndDiluted
Weighted average common shares outstanding, basic and diluted (in shares) 13,696,482us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted 8,718,199us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted